Rockwell Medical (RMTI) Notes Payables (2023 - 2026)

Rockwell Medical's Notes Payables history runs 4 years deep, the most recent figure standing at $66000.0 for Q1 2026.

• Quarterly Notes Payables fell 1.49% year-over-year to $66000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $66000.0 (down 1.49% YoY) and the FY2025 annual result came in at $264000.0, down 1.49% from the prior year.
• Notes Payables was $66000.0 for Q1 2026 at Rockwell Medical, down from $264000.0 in the prior quarter.
• Across five years, Notes Payables topped out at $670000.0 in Q2 2024 and bottomed at $66000.0 in Q1 2026.
• A 4-year average of $352222.2 and a median of $268000.0 in 2024 frame the typical range for Notes Payables.
• Annual changes were most pronounced in 2024 — Notes Payables increased 9.84% — and 2025, when it decreased 1.49%.
• Rockwell Medical's Notes Payables stood at $244000.0 in 2023, then grew by 9.84% to $268000.0 in 2024, then fell by 1.49% to $264000.0 in 2025, then plunged by 75.0% to $66000.0 in 2026.
• Business Quant data shows RMTI's Notes Payables at $66000.0 in Q1 2026, $264000.0 in Q4 2025, and $462000.0 in Q3 2025.